22nd Century Group (XXII) Reports Q1 Revenue of $22M, Net Loss of $18.2M; Guides FY23 Revenue of $105-$110M May 9, 2023 06:04AM
22nd Century Group (Nasdaq: XXII) Reports First Quarter 2023 Financial Results, Introduces 2023 Full Year Revenue Outlook May 9, 2023 06:00AM
22nd Century Group (Nasdaq: XXII) Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update Mar 9, 2023 06:00AM
22nd Century Group (XXII) Announces $21M Debt Financing to Expand Working Capital for Growth Initiatives Mar 3, 2023 04:05PM
22nd Century Group (XXII) Secures $21 Million Debt Financing to Expand Working Capital for Growth Initiatives Mar 3, 2023 04:05PM


Nov 8, 2022 06:02AM 22nd Century Group (XXII) Reports Q3 Revenue of $19.4M, Net Loss of $13.1M
Nov 8, 2022 06:00AM 22nd Century Group (Nasdaq: XXII) Reports Business Highlights and Financial Results for the Third Quarter 2022
Aug 9, 2022 04:43PM Cowen on 22nd Century Group (XXII): 'GVB provides an attractive platform for XXII to build on its existing capabilities in cannabis'
Aug 9, 2022 06:00AM 22nd Century Group (Nasdaq: XXII) Reports Business Highlights and Financial Results for the Second Quarter 2022
May 18, 2022 04:30PM 22nd Century Group (XXII) Begins Integration of GVB Biopharma
May 18, 2022 04:30PM 22nd Century Group (Nasdaq: XXII) Begins Integration of GVB Biopharma, Creating a Complete, Robust Hemp/Cannabis Platform